Literature DB >> 26638591

Neurological Recovery Determined by C-Reactive Protein, Erythrocyte Sedimentation Rate and Two Different Posterior Decompressive Surgical Procedures: A Retrospective Clinical Study of Patients with Spinal Tuberculosis.

Weera Sudprasert, Urawit Piyapromdee, Supphamard Lewsirirat.   

Abstract

BACKGROUND: C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) not only are useful in the diagnosis but also are reliable parameters in evaluating the response to treatment and prognosis of tuberculous spondylodiscitis.
OBJECTIVE: To analyze the correlation between neurological recovery and declination of CRP or ESR after two different posterior spinal procedures. MATERIAL AND
METHOD: The patients who had neurological deficit due to spinal tuberculosis and undergone spinal surgery between January 2009 and June 2013 were analyzed retrospectively. Posterior transforaminal decompression and interbody fusion were done in group I, whereas posterior transpedicular decompression and posterolateralfusion were performed on group II. Both groups were stabilized with pedicle screw instrumentation. Rapid recovery represented by improvement of at least one Frankel grade within 6 weeks after operation, otherwise it was slow recovery. Inflammatory markers were evaluated at initial diagnosis and at 6-week, 3-month, 6-month, and 1-year post-operation.
RESULTS: There were 31 patients. Group I included 14 cases and group II consisted of 17 cases. The median CRP and ESR at diagnosis were 80.4 mg/L and 78.0 mm/hour respectively. Rapid neurological recovery significantly related to the earlier declination of CRP within the first 6 weeks (p < 0.001). Considering the type of spinal procedures especially at thoracic and thoracolumbar level, neurological recovery in group I was significantly faster than in group II (p = 0.02; relative risk, 2.67; 95% confidence interval, 1.02 to 6.91).
CONCLUSION: Earlier declination of CRP within six weeks post-operation could determine rapid neurological recovery. Posterior transforaminal decompression and interbody fusion with instrumentation may be a suitable optionfor thoracic and thoracolumbar lesions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26638591

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  6 in total

1.  Characteristics and Management of Spinal Tuberculosis in Tuberculosis Endemic Area of Guizhou Province: A Retrospective Study of 597 Patients in a Teaching Hospital.

Authors:  Peng Wang; Wenbo Liao; Guangru Cao; Yongyan Jiang; Jingcheng Rao; Yi Yang
Journal:  Biomed Res Int       Date:  2020-01-30       Impact factor: 3.411

2.  Development and Validation of a Scoring System for Differential Diagnosis of Tuberculosis and Metastatic Tumor in the Spine.

Authors:  Shuang Cao; Xin Gao; Guangjian Bai; Baoquan Xin; Tao Wang; Jiashi Cao; Kai Lv; Chengzhang Zhu; Xiangzhi Ni; Weiwei Zou; Yejin Zhou; Jianru Xiao; Tielong Liu
Journal:  Infect Drug Resist       Date:  2021-02-04       Impact factor: 4.003

3.  Spinal Surgery and Subsequent ESR and WBC Changes Pattern: A Single Center Prospective Study.

Authors:  Akram Zare; Mohammadmahdi Sabahi; Hosein Safari; Arash Kiani; Meic H Schmidt; Mahdi Arjipour
Journal:  Korean J Neurotrauma       Date:  2021-10-18

4.  Surgical management of spontaneous thoracic and lumbar spondylodiscitis by fixation and debridement.

Authors:  Ahmed Hosameldin; Mohammed Hussein; Ehab Abdelhalim; Mohammed Shehab; Ashraf Osman
Journal:  Surg Neurol Int       Date:  2022-02-11

5.  Effect of Controlling Nutritional Status Score (CONUT) and Prognostic Nutritional Index (PNI) on patients after spinal tuberculosis surgery.

Authors:  Long-Yao Cao; Si Cheng; Lu Lin; Ming-Xin Chen
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996

6.  Efficacy, safety and prognosis of treating neurological deficits caused by spinal tuberculosis within 4 weeks' standard anti-tuberculosis treatment: A single medical center's experience.

Authors:  Chen-Guang Jia; Jian-Guo Gao; Feng-Sheng Liu; Zhuo Li; Zhao-Liang Dong; Li-Ming Yao; Lian-Bo Wang; Xiao-Wei Yao
Journal:  Exp Ther Med       Date:  2019-11-27       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.